Alnylam Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 52.59M 132.85M 2024-12
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 729M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Takeda JPY 7.42T 497.52B 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 677.61M 46.22M 2024-12



Alnylam Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.